Skip to content

Scrambled, Messy, and Squashed: The Cell’s Skeleton and a Toxin

Facebook
Twitter
LinkedIn
Tymoteusz Piasecki

Imagine swallowing a substance which suddenly causes your entire skeleton to collapse in on itself: all your bones squashed and squeezed together in the most unnatural positions. What a tragedy that would be! Luckily, such a toxin does not exist for humans, but it does at the cellular level. In fact, I (Tymoteusz Piasecki), together with my colleagues, supervised by Prof. Zenon Rajfur and his Ph.D. students at the Jagiellonian University of Kraków in Poland, focused on the effects of such a toxin (Cytochalasin D) on cells.

The skeletons of cells (the cytoskeleton) are made up of roughly three parts: threads called intermediate filaments, which help keep the shape of the cell; tubes called microtubules, which also help keep the structure of the cell in addition to helping transport materials inside the cell; and another type of thread, actin, which is partly responsible for cell movement. In fact, the toxin we used actually disrupts the actin part of the cytoskeleton.

I first video-recorded our cells without the toxin added. They looked quite healthy, able to divide and roam around the dish. However, upon adding a high concentration of the toxin Cytochalasin D, cell movement suddenly stopped as the cells became smaller and assumed spikier shapes. Next, I killed and stained the cells, not out of cruelty, but to observe them under a more complex confocal microscope in fluorescent light (see pictures). The cells with the toxin showed major abnormalities in the actin part of the cytoskeleton, which differed for different concentrations of the toxin. During the project, I should add that it was necessary to supply the cells with the correct food, making sure they did not overgrow while also keeping everything sterile to prevent bacterial infections.

I then analysed the recordings to obtain data such as changes in direction of movement, velocity, area, etc. and look for any patterns. One such numerical outcome was that, upon adding the toxin, the area taken up by the cells decreased, pointing to large changes in the cells’ internal structures. These results are to be used in future projects by the researchers.

In general, toxins which affect the cytoskeleton (such as Cytochalasin D itself) are, in fact, used to study the cell’s skeleton, but some are also used as pesticides. More importantly however, these toxins are used in certain medicines as well as chemotherapeutic agents, which makes this field of research truly an important one.

The following colleagues worked with me on the project: Daria Chigarina, Agata Cournuaud, Dawid Marcisz, and Piotr Musiał, supervised by the following Ph.D. students: Armin Mirzaki Ebrahimi, Asia Hajduk, and Tomasz Kołodziej.

Tymoteusz Piasecki is currently following a course leading to Doctor of Medicine and Surgery at the Faculty of Medicine and Surgery, University of Malta. The internship at the Jagiellonian University in Kraków, Poland was organised independently by the author.

Author

More to Explore

Molecular Mail: Tiny Parcels for Tracking Tumours

Tumours are not discreet. As cancer cells grow and change, they release microscopic particles into their environment. Some of these particles enter the bloodstream. They are small, abundant, and, as researchers are beginning to realise, potentially informative. A Maltese research project is testing whether extracellular vesicles can provide a less invasive source of cancer information.

The Colour of Malta

Matylda Maria Jarosz is an artist who recently exhibited Walking the Coastline, which uses materials from Malta’s natural space to depict that same wilderness. Following her experience and master’s at the University of Malta, she will be teaching courses on Contemporary Weaving and Sustainable Art later in the year. THINK’s Jonathan Firbank speaks with Jarosz about her Master of Arts project, and the journey it represents.

The Doctor’s New Partner: Artificial Intelligence in Medicine

For centuries, medicine has balanced science with experience and intuition. Two patients with the same diagnosis may receive the same treatment, yet their outcomes can differ dramatically. That has long been one of medicine’s most frustrating mysteries, and one of its biggest challenges. Today, artificial intelligence (AI) is beginning to close this gap. What was once a vision of the future is now entering clinics, laboratories, and even operating rooms, redefining how care is delivered and how doctors and patients interact.

Comments are closed for this article!